Opportunities & Gaps in the European In Vitro Diagnostic Market - By Products & Services; By Technology; By Therapeutic Application; By End User and By Region (European Region, Germany, France, The United Kingdom

  • ID: 4752600
  • Report
  • Region: Europe, France, Germany, United Kingdom, Great Britain
  • 155 pages
  • Stratview Research
1 of 4
This report, from the author, studies the European in vitro diagnostics market over the trend period of 2014 to 2017 and forecast period of 2018 to 2025. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.

The Burning Questions This Report Will Answer:
  • Which are the major import and export hubs for IVD players in Europe? Is it all across major markets or does it differ in Germany and France?
  • Who are the domestic players in the country level IVD market? Which sectors they are dominant and/or where are they absent?
  • Which disease pattern will drive the future of IVD market in Europe? Especially in Germany, France and UK?
  • Will Brexit impact the IVD players? What are the regulatory changes that are expected in 2019 and 2022?
European In Vitro Diagnostics Market (Major Focus on Germany, France and The United Kingdom)
It should not come as a surprise that while the markets in Britain may face some fluctuations due to Brexit, major players in Britain are hopeful that with the new dynamics, newer opportunities will knock the doors of UK’s IVD market. Germany shall remain the market leader followed by France at No. 2 position, followed by Italy. Among the smaller nations, Poland, Czech Republic, Romania, Ireland and United Kingdom will show more growth than the remaining European nations. The report explores the opportunities and gaps in the top two IVD market of Europe as well as the most watched IVD market in 2018-2019, i.e., the UK.

On one hand the report deals with the Typology of out-of-pocket payments per country which varies in European member states which leads to varied payments by patients in different countries (impacts the cost of IVD tests) and on the other hand, it also looks at the attractive segments where IVD companies may come across decision makers and focus their marketing strategies accordingly. Infectious diseases, oncology, life style diseases shall remain the top three attractive segments in Europe.

Europe accounts for 23.4% of global cancer cases and 20.3% of cancer deaths, although it has only 9 per cent of the global population. Europe is characterized by striking geographical differences in cancer occurrence. There were an estimated 3.5 million new cancer cases and 1.9 million cancer deaths in Europe in 2012. Cancers of the female breast, colo-rectum, prostate and lung constitute over half of the overall incidences, while lung and colorectal cancer rank as the most common causes of cancer death. It widely varies from country to country.

In men, prostate cancer is the most frequent form of cancer incidence in most Northern, Western and Southern European countries, while lung cancer is the most frequently diagnosed cancer in Central and Eastern Europe. Lung cancer is the leading cause of cancer death among men in almost all European countries, while breast cancer dominates as the most frequent in women. Lung cancer is also a leading cause of cancer death in certain European countries among women, overtaking breast cancer.

While breast cancer incidence rates continued to increase in most European countries, mortality rates decreased, as a result of earlier diagnosis and improved therapies. IVD market is attractive and prominent among the oncologists. Besides, therapy area, the report highlights the attractiveness in products and services, end user markets.

The study looks at the major import and export IVD markets in Europe and analyses the trends from 2014 till date. It also provides country wise data i.e. Import and export destinations in Germany, France and UK from 2014, while giving insights on changing dynamics between new emerging markets for IVD companies. The report highlights the teething issues of new investors in markets such as Germany, UK and France and guide them through the “do’s and don’ts in the market”.

Research Methodology
Our reports offer high-quality insights and are the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with the author’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact book, press release, journals, investor presentation, white papers, patents, and articles have been leveraged to gather the data. About 20 detailed primary interviews with the market players across the value chain in all four regions and industry experts have been executed to obtain both the qualitative and quantitative insights.

Report Features
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market.

The following are the key features of the report:
  • Market structure: Overview, industry life cycle analysis, disease patterns and demand for IVD
  • Market environment analysis: Growth drivers and constraints, Uncertainty Matrix, IVD life cycle analysis, etc.
  • Market trend and forecast analysis
  • Market segment trend and forecast
  • Competitive landscape and dynamics: Market share, Domestic versus Global IVD
  • Regulations
  • Attractive market segments and associated growth opportunities
  • Import – Export Trade Analysis (2014 – Present)
  • Strategic growth opportunities for the existing and new players
  • Gaps in the regions and opportunities for the providers
  • How To Invest? How to plan investment in the new market? What are “to do” list in each market? If the buyers country has trade agreements with the destination IVD market?
European In Vitro Diagnostics Market - Segmentation

By Products & Services
  • Reagents & Kits
  • Equipment
  • New Technology/Connect Laboratories (AI in lab)
  • Data Management Services
  • Laboratory Support Services
By Technology
  • Immunohistochemistry
  • Clinical Chemistry
  • Molecular Diagnostics
  • Urinalysis
  • Hematology
  • Microbiology
  • POCT
  • Coagulation
  • Others
By Therapy Area
  • Infectious Diseases
  • Life Style Diseases (Diabetes, Obesity, etc)
  • Oncology
  • Cardiology
  • Nephrology
  • Autoimmune Disorder &
  • Drug Testing
By End User
  • Hospital – Laboratories / ICU/ Care Units
  • Hospitals – Patient Bedside (POCT)
  • Advanced Clinical Laboratories (Referred by physicians)
  • Self-Tests / Walk ins
  • Research and Academic Laboratories
  • Home users/ Aged Care/ Long Term Care/Hospice/ Community Care
By Region
  • European Region (EU as single market)
  • Germany (As Country Market)
  • France (As Country Market)
  • The United Kingdom (As Country Market)
  • (Extra Coverage – Eastern Europe, Romania, Switzerland, Austria, Poland, The Netherlands, Sweden, Spain, Ireland for market share and import and export data)
Note: Product cover images may vary from those shown
2 of 4
1. European Union In Vitro Diagnostic Market
1.1 Healthcare Dynamics and Demand for Diagnostics
1.2 Trends from The In Vitro Diagnostic (IVD) Market
1.3 Healthcare Dynamics in Three Most-Attractive IVD Markets
1.4 Near Term Growth in the European In Vitro Diagnostic (IVD) Market (2014-2020)
1.5 The European Union The In Vitro Diagnostic Market
1.6 Growth Forecast of The In Vitro Diagnostic Market
1.7 The European IVD Market
1.8 Long Term Growth Forecast of The In Vitro Diagnostic Market in Europe
1.9 Europe –The In Vitro Diagnostic Market By Products & Services
1.10 Top Three Products & Services Market for IVD - Reagents and Kits
1.11 Top Three Products & Services Market for IVD - AI in Lab/Lab on A Chip
1.12 Top Three Products & Services Market for IVD - Equipment/Instruments
1.13 Europe –The In Vitro Diagnostic Market By Technology
1.14 Top Three Markets for Technology in The European IVD Market – Point of Care Testing
1.15 Top Three Markets for Technology in The European IVD Market – Immuno-histo-chemistry
1.16 Top Three Market for Technology in European IVD Market – Molecular Diagnostics (MDx)
1.17 Europe –The In Vitro Diagnostic Market By Therapeutic Applications
1.18 Top Three Opportunistic Therapeutic Areas – Infectious Diseases
1.19 Europe –The In Vitro Diagnostic Market By End User
1.20 Top Three End User Markets for IVD – Hospitals
1.21 Top Three End User Markets for IVD – Self Testing
1.22 Top Three End User Markets for IVD – Home Care / Aged Care/ Hospice
1.23 Europe –The In Vitro Diagnostic Market By Site Of Testing
1.24 Europe – Key Export Destinations in The In Vitro Diagnostic Market
1.25 Europe – Key Import Destinations in The In Vitro Diagnostic Market
1.26 Europe: The Regulatory Process for In Vitro Devices (IVD)
1.27 Europe: Time, Cost, and Complexity of IVD Registration
1.28 The European IVD Market – Regulations for The IVD Market Post May 22, 2019
1.29 The European IVD Market – Regulations for The IVD Market Post June 2022
1.30 The European IVD Market – Where Should You Focus To Convert Competitor Loyalists?
1.31 The European IVD Market – Gaps in the region, Opportunities for the Providers

2. Germany In Vitro Diagnostic Market
2.1 Introduction
2.2 Current Regulations
2.3 German IVD Segment Life Cycle Analysis (2018-2019)
2.4 German IVD Market Impact Analysis – Drivers & Restraints
2.5 German IVD Market – By Long Term Growth Forecast (2018e-2025f)
2.6 German IVD Market – By Products & Services (2018e-2025f)
2.7 German IVD Market – By Technology (2018e-2025f)
2.8 German IVD Market – By Therapeutic Areas (2018e-2025f)
2.9 German IVD Market – By End Users (2018e-2025f)
2.10 German IVD Market – By Domestic Competition
2.11 German IVD Market – Global Competition
2.12 German IVD Market – The News Makers in 2018
2.13 Are You Planning To Invest in 2019-2020? – Why Germany?
2.14 Are You Planning To Invest in 2019-2020? – Who will support your business? Where can you get funding?
2.15 Are You Planning To Invest in 2019-2020? – How To Initiate?
2.16 Are You Planning To Invest in 2019-2020? – Do you get benefited due to the bilateral trade agreements between Germany and your home country?
2.17 Germany – Key Export Destinations in The In Vitro Diagnostic Market
2.18 Germany – Key Import Destinations in The In Vitro Diagnostic Market

3. French In Vitro Diagnostic Market
3.1 Introduction
3.2 French IVD Segment Life Cycle Analysis
3.3 French IVD Market Impact Analysis – Regulations
3.4 French IVD Market Impact Analysis – Drivers & Restraints
3.5 French IVD Market – By Long Term Growth Forecast (2018e-2025f)
3.6 French IVD Market – By Products & Services (2018e-2025f)
3.7 French IVD Market – By Technology (2018e-2025f)
3.8 French IVD Market – By Therapeutic Area (2018e-2025f)
3.9 French IVD Market – By End Users (2018e-2025f)
3.10 French IVD Market – By Domestic Competition
3.11 Are You Planning To Invest in 2019-2020? – Why France?
3.12 Are You Planning To Invest in 2019-2020? – What are the attractive segments?
3.13 Are You Planning To Invest in 2019-2020? – How To Initiate?
3.14 France – Key Export Destinations in The In Vitro Diagnostic Market
3.15 France – Key Import Destinations in The In Vitro Diagnostic Market

4. The United Kingdom In Vitro Diagnostic Market
4.1 The UK In Vitro Diagnostic – Introduction
4.2 Segment Life Cycle Analysis
4.3 Market Impact Analysis – Drivers & Restraints
4.4 Key Market Driver “Disease Pattern Changing”
4.5 Key Market Driver “Initiatives by AMR DC”
4.6 Key Market Restraint “POCT is promising but adoption is full of roadblocks in primary care setups”
4.7 Current Regulations for IVD Manufacturers
4.8 The UK IVD Market – Long Term Growth Forecast (2018e-2025f)
4.9 The UK IVD Market – By Products & Services (2018e-2025f)
4.10 The UK IVD Market – By Technology (2018e-2025f)
4.11 The UK IVD Market – By Therapeutic Areas (2018e-2025f)
4.12 The UK IVD Market – By End Users (2018e-2025f
4.13 The UK IVD market – By Domestic Competition
4.14 The UK IVD market – News Makers in 2018
4.15 Are You Planning To Invest in 2019-2020? – Why the UK?
4.16 Are You Planning To Invest 2019-2020? – What are the attractive segments? Is the UK the best market to invest?
4.17 The UK – Key Export Destinations in The In Vitro Diagnostic Market
4.18 The UK – Key Import Destinations in The In Vitro Diagnostic Market

5. Rest Of Europe – Potential IVD Markets
5.1 Potential The In Vitro Diagnostic Markets – Rest of Europe
5.2 Italy – Key Export Destinations in The In Vitro Diagnostic Market
5.3 Italy – Key Import Destinations in The In Vitro Diagnostic Market
5.4 Spain – Key Export Destinations in The In Vitro Diagnostic Market
5.5 Spain – Key Import Destinations in The In Vitro Diagnostic Market
5.6 Switzerland– Key Export Destinations in The In Vitro Diagnostic Market
5.7 Switzerland – Key Import Destinations in The In Vitro Diagnostic Market

6. Key Recommendations
6.1 Key Emerging Trends
6.2 Key Success Factors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Thermo Fisher
  • Bio-Rad
  • Roche
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4752600
Adroll
adroll